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7DEBATE Open AccessConfusion over live/dead stainings for the
detection of vital microorganisms in oral
biofilms - which stain is suitable?
Lutz Netuschil1*, Thorsten M Auschill2, Anton Sculean3 and Nicole B Arweiler1Abstract
Background: There is confusion over the definition of the term “viability state(s)” of microorganisms. “Viability
staining” or “vital staining techniques” are used to distinguish live from dead bacteria. These stainings, first
established on planctonic bacteria, may have serious shortcomings when applied to multispecies biofilms. Results
of staining techniques should be compared with appropriate microbiological data.
Discussion: Many terms describe “vitality states” of microorganisms, however, several of them are misleading.
Authors define “viable” as “capable to grow”. Accordingly, staining methods are substitutes, since no staining can
prove viability.
The reliability of a commercial “viability” staining assay (Molecular Probes) is discussed based on the corresponding
product information sheet: (I) Staining principle; (II) Concentrations of bacteria; (III) Calculation of live/dead
proportions in vitro. Results of the “viability” kit are dependent on the stains’ concentration and on their relation to
the number of bacteria in the test. Generally this staining system is not suitable for multispecies biofilms, thus
incorrect statements have been published by users of this technique.
To compare the results of the staining with bacterial parameters appropriate techniques should be selected. The
assessment of Colony Forming Units is insufficient, rather the calculation of Plating Efficiency is necessary. Vital
fluorescence staining with Fluorescein Diacetate and Ethidium Bromide seems to be the best proven and suitable
method in biofilm research.
Regarding the mutagenicity of staining components users should be aware that not only Ethidium Bromide might
be harmful, but also a variety of other substances of which the toxicity and mutagenicity is not reported.
Summary:
– The nomenclature regarding “viability” and “vitality” should be used carefully.
– The manual of the commercial “viability” kit itself points out that the kit is not suitable for natural multispecies
biofilm research, as supported by an array of literature.
– Results obtained with various stains are influenced by the relationship between bacterial counts and the
amount of stain used in the test. Corresponding vitality data are prone to artificial shifting.
– As microbiological parameter the Plating Efficiency should be used for comparison.
– Ethidium Bromide is mutagenic. Researchers should be aware that alternative staining compounds may also be
or even are mutagenic.
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The definition of the so-called “viability state(s)” of mi-
croorganisms has been a matter of confusion and dis-
cussion for decades (for a glimpse of the plethora of
literature see [1-5]). Recently two manuscripts discussed
this topic. Hannig et al. [6] investigated the influence of
a novel mouthwash containing hydroxyapatite micro-
clusters on bacterial adherence by using the BacLight™
live/dead staining technique. Tawakoli et al. [7] com-
pared different live/dead stainings “for detection and
quantification of adherent microorganisms” in the initial
oral biofilm. In line with earlier literature these two arti-
cles demonstrate that serious attempts have been made
in the past decades to define the different states between
dead and live (marine and oral) microorganisms, and
that “viability staining” or “vital staining techniques”
have been and are still used as a trial to overcome the
problem of distinguishing between live and dead micro-
organisms in biofilms.
In recent years more and more scientists in dental bio-
film research have become familiar with commercially
available vitality/viability stains, especially the BacLight
Assay (BLA; BacLight™ live/dead staining technique).
However, this staining principle has severe shortcomings
when applied to undefined natural multispecies biofilm
samples. Results of this and other staining techniques
should be compared to classical microbiological tech-
niques like the assessment of colony forming units
(CFU) and, more reliable, the calculation of bacterial
plating efficiency (PE). These comparisons with a “gold
standard” are quite rare when commercial kits are used
in biofilm research. Furthermore, components of these
vital stains may be potentially mutagenic.
In summary, the purpose of this manuscript is to de-
bate the basis, usefulness and the risk of “viable” and
“vital” stains especially in biofilm research, with specific
attention to natural dental biofilms and vital fluorescence
staining with Fluorescein Diacetate/Ethidium Bromide [8].
From a scientific point of view, it is important that data
derived from such staining techniques should reflect the
bacterial status correctly.
Discussion
What is the root of the problem?
From a holistic point of view the debate covers different
levels. First, the discrimination of dead or alive microor-
ganisms represents a crucial problem in (environmental)
bacteriology. This basic problem has existed for decades
and has not yet been solved. In this respect, the terms
“vitality” and “viability” are often used and quite often
mixed - some researchers completely interchange these
terms [9].
Second, “vital stains” are generally only surrogates, but
are quick and simple devices in studies examining, forexample, the antibacterial effect of substances. Here the
problem is the large variety of staining substances and
thus of staining principles, so that the “plethora of
choices adds to confusion” [10]. Similarly Pamp et al. [11]
state: “More recently developed stains, such as the Syto
stains …. can efficiently stain cells in virtually any color
of the rainbow”. That might sound humorous – but
merely reflects the problem. As just mentioned, Tawakoli
et al. [7] used combinations of several stains (for ex-
ample FDA, cFDA, TCFDA, EB, as well as SYTO 9/PI,
Sytox red, besides Calcein AM). Davey [10] also refers to
FDA, PI and SYTO 9, but moreover to substances like
SYTO green I, DIBAC4, pyronine Y, rhodamine 123 and
thiazole orange. It is no wonder that this author [10] re-
fers to another four reviews only to inform about the
“modus operandi” of the different fluorescent stains and
the “huge diversity of possibilities in terms of stain selec-
tion, concentration, staining time, etc”.
When analyzing further, the problem becomes even
more complex. Some authors criticize the limited use of
propidium iodide (PI) as a cell viability (sic!) indicator
[12,13], while others monitored striking differences be-
tween SYTO 9 and SYTO 12 regarding the influence of
porins on uptake kinetics of these dyes [14]. This means
that when antibacterial substances disturbing the cell
membrane integrity are assessed the use of those vital
staining techniques may be misleading. An inherent as-
pect of this problem, namely the suitability of staining
methods, is the dependency on the stains’ concentrations
of the results (see later).
Third, the users are for the most part unfortunately
unaware that such “seductive” tests have only been vali-
dated for a very limited number of bacterial species
[13,15]. From 15 000 “hits” (250 reviews) generated in
PubMed by asking for “flow cytometry & bacteria”, only
three were left after filtration of the database when using
“biofilm” as an additional tracing term. None of this
three articles contributes to the debate.
It is crucial that “vital stains” and, much more import-
ant, their combinations are directly compared to con-
ventional bacteriological data. As discussed later in
detail this cannot be the assessment of CFU, but of PE.
In dentistry some corresponding work has been com-
pleted using single or a lucid number of species in vitro
without conducting bacteriological tests [6,16-18], while
some companies used this staining method trusting per
se in its reliability [19,20]. When the SYTO 9/PI com-
bination was in fact related to corresponding micro-
biological assessments the outcome was inconsistent
[21-23]. In our opinion it is impossible to find out stud-
ies where particular examples of these vital stains and its
combinations were properly compared and related to
microbiological data concerning natural multispecies
biofilms like dental plaque.
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With respect to the list of compounds, as previously
mentioned and excerpted from [7] and [10], it must be
determined whether there is a harm or risk in the use of
these substances.
Viability versus Vitality
Netuschil [8] recorded 49 terms to describe “vitality
states” of microorganisms (for example: active microbes,
cryptic growth, direct viable count [DVC], progressive
dormancy, vegetative dormancy, dwarf cells, moribund
cells, nonculturability, nonplateable, stasis survival, re-
productive viability, viable but not culturable [VBNC],
non-viable but resuscitable, vital, viviform, etc.) as cited in
34 different corresponding publications [1,2,4,24-54]
(cf. Table 1). While the table displays references from
1962 up to 1998, the debate is older and was already rele-
vant at the turn of the 19th to the 20th century [55-60].
One example is the “Great Plate Count Anomaly” [61,62]
see also [63]. Even at that time vital stainings were debated
to be used as a trial to overcome the shortcomings of cul-
ture techniques [64-68]. It seems that the past discussion
[69] was “revitalized” at the turn of this century [41,70-78].
Of note is that some terms (e.g., dormant, VBNC) are even
relevant when referring to probiotic bacteria [79,80].
Unfortunately, several of the terms found and used in
publications are incorrect, misleading or even paradox-
ical, especially the often used term “viable but not cul-
turable (VBNC)”, which blurs the line between vitality
and viability. To minimize confusion as much as pos-
sible we refer to Kaprelyants et al. [4]: “Several classifica-
tions of the physiological states of microorganisms have
been presented. We have previously suggested [3] that all
the cell types considered could be reduced to three
groups, as follows: ‘viable’ to refer to a cell which can
form a colony on an agar plate, ‘vital’ to refer to one
which can only do so after resuscitation and ‘non-viable’
to refer to a cell which cannot do so under any tested
condition. According to this terminology, dormant cells
are vital” (see Table 2).
In accordance with [4] we define “viable” strictly as
“capable to grow”. In this respect any other tests, for ex-
ample elongation tests (DVC; [50]) or staining methods,
are merely proxies, since no kind of staining can prove
viability. Thus, the term “viability stain” is a misnomer
per definitionem and these stains should correctly be
named “vital stains”. Unfortunately, the misnomer is fre-
quently used by Invitrogen Ltd. (BacLight™), and is con-
sequently – but incorrectly – adopted by the users of
these vitality tests.
The BacLight™ bacterial viability kit (BacLight Assay, BLA)
According to the manufacturer [81] BLA consists of two
stains, propidium iodide (PI) and SYTO 9, which bothstain nucleic acids. SYTO9 is a green fluorescing inter-
calating membrane permeable molecule and stains all
cells. In contrast, PI is a red intercalating stain and is
membrane impermeable, and is therefore excluded by
“healthy” cells. The manufacturer describes that PI has a
stronger affinity to nucleic acids than SYTO 9; thus,
when both stains are present within a cell, SYTO 9 will
be displaced from nucleic acids and the cell(s) will fluor-
esce in red. To prove the mechanism Stocks [82] con-
ducted “cell-free” physicochemical measurements with
the “Viability Stain, BacLight”, and could reveal that the
staining principle is not that simple. This author estab-
lished a so-called fluorescence resonance energy transfer
(FRET), though, under certain staining conditions, SYTO
9 emission surpasses the PI emission. Increasing the
SYTO 9 concentration may thus enhance the PI emission,
causing a double staining of cells. Stocks [82] emphasizes
several times that for an interpretation of the staining out-
come “the relative concentrations of PI, SYTO9 and DNA
were of crucial importance” and “that appropriate control
or validation experiments (should be) performed”. Double
staining and/or FRET was also documented by other au-
thors [41,83], who examined viability parameters of viable
and formaldehyde-killed or UVA-treated cultures, respect-
ively. The following discussion of the MOLECULAR
PROBES manual should be viewed in this context.
Concerning the reliability of the “viability kit” used in
biofilm research we would like to directly cite the product
information sheet(s) of MOLECULAR PROBES 2001;
Product Information LIVE/DEAD ® BacLight™ Bacterial
Viability Kit, Revised: 26-January-2001, as well as Revised:
15-July-2004 (whereby the latter represents the most
current version in October 2013) [81]:
(I) “… stains differ both in their spectral characteristics
and their ability to penetrate healthy bacterial cells.
When used alone, the SYTO 9 stain generally labels
all bacteria in a population – those with intact
membranes and those with damaged membranes. In
contrast propidium iodide penetrates only bacteria
with damaged membranes, causing a reduction in
the SYTO 9 stain when both dyes are present. Thus,
with an appropriate mixture of the SYTO 9 and
propidium iodide stains, bacteria with intact cell
membranes stain fluorescent green, whereas bacteria
with damaged membranes stain fluorescent red."
(II) “Staining Bacteria with either Kit L7007 or L7012 -
4.1 Adjust the E. coli suspensions (live and killed) to
1 × 108 bacteria/mL or the S. aureus suspensions
(live and killed) to 1 × 107 bacteria/mL. S. aureus
suspensions typically should be 10-fold less
concentrated than E. coli for fluorescence microscopy.”
Hence the numbers of E. coli and S. aureus differ
by one logarithm.
Table 1 Terms used to describe “vitality states” of
microorganisms (from [8])
Acclimation [30] “Quiescent cells” [17]
Active microbes [20] Resuscitation [3,4,15,24,28-31]
Alive, “aliveness” [15] “Shut down cells”, “shut down state”
[17]
“Anabiotic (dormant) state” [15] Somnicells [8,11,30]
“Bags of enzymes” [4,12] Starvation [10,17,29]
Cryptic growth [24,26,27,29] – “True starvation” [15]
Culturable, culturability [4,10,11,31] “Substrate accelerated death”, “substrate
– Nonculturable, nonculturability
[22,24]
Accelerated stress” [6,15,26,29,31,33]
Debilitation [9] Survival [5,11,20,22,29]
Dead, death
[3,4,9,11,15,16,20,26,29]
– “Survivability” [3]
– “Death phase” [15,29] – “Stasis survival” [25]
“Die-off” [31] Viable [3,10,15,16,18,30,31]
Direct viable count (DVC), DVC
method [3,4,10,15,18,29-31,34]
– Non viable [3,15,16,20]
Viability
[3,4,6,9,12,13,15,16,19,22,23,26,29]
Dormant, dormancy
[11,12,15,20,23,28-30,32]
– “Apparent viability” [6,15]
– “Progressive dormancy” [1,30] – “Reproductive viability” [23]
– “Vegetative dormancy” [15] – “True viability” [6]
Dwarf cells, inactive dwarfs,
ultramicrobacteria [6,14,15,29,32]
“Viable but nonculturable” (VBNC)
[3,4,8,10,12,15,16,21,22]
Growth arrest [25] – VBNC hypothesis [2-4,7]
“Killer phenotype” [15] – VBNC state
[3,4,10,22,24,29,31,33,34]
Lysis [20] – “Viable but nonrecoverable” [31]
Moribund cells [29] – “Non-viable but resuscitable” [16]
'Nonplateable" [24] – “Unculturable but viable” [28]
Protistan grazing [11] Vital, vitality [15,16,26]
“Pseudosenescent” [29] Viviform [11,30]
References:
1BARCINA et al. 1989 [24] 18KOGURE et al. 1979 [40]
2BARER et al. 1993 [25] 19KORBER et al. 1996 [41]
3BOGOSIAN et al. 1996 [26] 20MASON et al. 1986 [1]
4BOGOSIAN et al. 1998 [27] 21MCKAY 1992 [42]
5BOWDEN & HAMILTON
1998 [28]
22MORGAN et al. 1993 [43]
6BUTTON et al. 1993 [29] 23NEBE-VON CARON et al. 1998 [44]
7COLWELL 1993[30] 24NILSSON et al. 1991 [45]
8COLWELL et al. 1985 [31] 25NYSTRÖM 1995 [46]
9DAWE & PENROSE 1978 [32] 26POSTGATE 1977 [47]
10DUNCAN et al. 1994 [33] 27POSTGATE & HUNTER 1962 [48]
11GONZÁLES et al. 1992 [34] 28ROSE et al. 1990 [49]
12GRIBBON & BARER 1995 [35] 29ROSZAK & COLWELL 1987a [2]
13HÖFLE 1983 [36] 30ROSZAK & COLWELL 1987b [50]
Table 1 Terms used to describe “vitality states” of
microorganisms (from [8]) (Continued)
14HOOD et al. 1987 [37] 31ROSZAK et al. 1984 [51]
15KAPRELYANTS et al. 1993 [4] 32STEVENSON 1978 [52]
16KELL et al. 1991 [38] 33WHITESIDES & OLIVER 1997 [53]
17KOCH 1996 [39] 34WILSON & LINDOW 1992 [54]
Netuschil et al. BMC Oral Health 2014, 14:2 Page 4 of 12
http://www.biomedcentral.com/1472-6831/14/2(III) Lastly, due to (I) a mixture of 50% living and 50%
dead bacteria does not normally lead to a 50/50
green/red fluorescence. And vice versa: 50% of
green fluorescing bacteria in a sample does not
mean that there are 50% vital cells. Therefore,
“green/red fluorescence ratios (have to be)
calculated for each proportion of live/dead E. coli.”
This last point was confirmed by Hannig et al. [6] in
their paper concerning the viability of S. mutans in vitro.
They determined that an “initial concentration of viable
bacteria in the assay” of 50% leads to different “ratio
emission vital/emission dead bacteria” values of about
9.5, 6.5 or 8.0 in their NaCl-control samples. Further-
more, Hannig et al. [6] state that “the proportion of avi-
tal bacteria increased as indicated by the ratio of avital
to vital cells. It ranged between 0.1… and … 29.0 … After
rinsing with chlorhexidine, the ratio amounted to 190
(6 h) or 10.2 (12 h)…” Taking the information of their
Figure one into account, it remains unclear what these
different ratios actually may mean in terms of “real” vi-
tality values.
In summary, the three above-mentioned points de-
scribed in the BLA user’s manual show that, in accord-
ance with Stocks [82], an “appropriate mixture” of the
two stains must be determined and established for any
single species of bacteria before using them in an experi-
ment. This may be possible in an in vitro situation,
where the BLA may help to save time in the long run
following critical, careful, and time consuming calibra-
tion steps for each individual bacterial species. However,
this is impossible to manage in naturally occurringTable 2 “Glossary of terms used to describe the 3 major
physiological states defined herein” (cited from [3])
Physiological
state
Phenotype
Viable Capable of division; will form a colony on an agar plate.
Vital or dormant Unable to divide or to form a colony on an agar plate
without a preceding resuscitation phase.
Non-viable Incapable of division; will not form a colony on an
agar plate under any tested condition.
We use the phrases ‘starvation’ or ‘starving cells’ to refer to the environmental
conditions under which cells are incubated, rather than to a physiological state.
Thus starved cells (or cells that have suffered other stresses) may or may not be
dormant. Despite historical usage of these terms, the phrases ‘direct viable count’
and ‘viable-but-non-culturable’ are misnomers, since such cells are not viable as
defined above.
Table 3 Background information concerning the use of
the BacLight® assay (BLA) for assessment of (dental)
biofilm vitality
Studies using the BLA
(n = 30)
[5-7,9,16-20,22,23,41,71,73,82* 83,85-98]
(a) Were plaque-like
biofilms evaluated?
No: [5,16-18,22,23,41,82,83,86,87,93,96-98]
Yes: [6,7,9,19,20,71,73,85,88-92,94,95]
(b) Validation No:
[5,7,9,16-18,20,22,23,41,71,73,82,85-91,94-98]
Yes: [6, 19?, 83, 92, 93?]
(c) Dilution factor Not stated: [16,18,23,73,86,94,95,98]
1:1 [6,7,9,17,20,22,41,71,85,87-92,96,97]
2:1 [93]
4:1 [5]
6:4 [19]
1:6 [83]
(d) Incubation procedure Not stated: [16,18,71,86,95,96]
10 min, RT [6,7,20]
15 min, RT
[5,9,17,19,22,23,41,73,85,87-91,97,98]
20 min, RT [83,92]
>20 min, 2°C [93]
30 min [94]
(e) Comparison No: [16-18,20,22,71,82,83,85,88,90,91,94,95]
Yes: [5-7,9,19,23,41,73,86,87,89,92,93,96-98]
(f) … with inappropriate
methods
[6,7,9,19,23,41,73,86,87,89,92,93,96-98]
(g) … with appropriate
methods
[5]*
(h) Did the BLA results fit to
the other parameters?
No: [7,19,86,89,92,93 (DAPI), 96,97]
Yes: [5,23,41,93 (FDA), 98]
(i) Did the BLA results
meet the expectations
of the user(s)?
No: [23,83,86]
Yes: [5,7,16,18-20,22,41,71,82,85,87-98]
(a) to (i) see description in the text.
Not stated: Either no information was given by the authors, or the authors
stated that the staining was conducted “according to the manufacturer’s
instructions”, what means generally a dilution factor of 1:1, and an incubation
time of 15 minutes.
*[5]: Decker registered the total bacterial counts (as log BC/ml) and the CFU
(as log CFU/ml), however gave no data regarding the PE.
*[82]: “cell-free” physicochemical measurements to elucidate the mechanism
of the BacLight staining procedure.
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films where in reality there may be more or less than
1000 different microbial species [84]. Moreover the ap-
plication of the SYTO 9/PI stain is not considered suit-
able for biofilms, because of diffusion phenomena due to
exo-polymers that result “in an underestimation of vi-
able counts” [21].
However, there seems to be an additional drawback.
Giertsen et al. [23] criticized considerable discrepancies
between expected biofilm vitality and the outcome of
the SYTO 9/PI staining method. Moreover, these au-
thors described an instable behavior and a change of the
staining color from green to red, i.e. towards monitoring
more “dead” bacteria. Just recently these findings were
explained by Tawakoli et al. [7] postulating that stained
cells lost their viability shortly after intercalation of the
dyes, writing: “This hypothesis was confirmed by the
TEM analysis in the current study (Figure two). The im-
ages showed immense lysis and destruction of the adher-
ent cells ….”
Table 3 lists a plethora of studies [5-7,9,16-20,22,23,41,
71,73,82,83,85-98] that used the BLA. However, in almost
all studies it had to cleared up (a) if plaque-like biofilms
or, at least, saliva samples were evaluated, or if the investi-
gations were made with single bacterial species and/or
artificial (monospecies) biofilms; (b) if the staining regime
of the biofilm samples was adjusted according to the BLA
manual (validation); (c) which dilution factor was used be-
tween SYTO 9 and PI, due to a validation procedure ac-
cording to (b); (d) how the incubation procedure was
followed, especially the incubation time of the bacterial
samples together with the stains’ mixture; (e) whether the
results of the BLA were compared to other parameters,
and if the latter were appropriate (g) or not (f); (h) if the
BLA results fit with the other parameters (whether appro-
priate or not). Last not least we were interested (i) whether
the BLA results met the expectations of the users.
From the 30 investigations listed in Table 3 one half (15)
was classified in the rubric “plaque-like biofilm”. This high
portion is due to the fact that we endeavored to consider
literature concerning oral biofilms. Natural saliva was also
included e.g. [89-91] as well as “microcosm plaques”, which
were grown in an artificial mouth and/or were for example
established from saliva [20,71,92] or from a subgingival
plaque sample [96]. Some other studies dealt with deep-sea
sediment bacteria or wastewater samples [73,93], which
were considered by us as natural multispecies systems.
It is astonishing, but expected, that only five studies
were based on a preceding validation procedure (line (b)
in Table 3) [6,19,83,92,93], from which two cases were
even questionable [19,93]. Nevertheless, a calibration
could be assumed there. The description of Filoche et al.
[92] clarifies the laborious methodology (cf. their Materials
& Methods section, paragraphs 2.5 Generation of theviability standard; 2.6 Preparation of the individual plaque
viability standard, 2.7 Preparation of the pooled viability
standard; 2.8 Staining protocol for Live/Dead® BacLight™
and 2.9 Fluorescence measurement and data analysis).
Surprisingly, the calibration procedure of these authors
[92] even seemed to work when samples and controls
were fixed in 4% paraformaldehyde, and/or were stored
for up to three months.
As a consequence of having no validation the utmost
users rely in the manufacturer’s advices regarding the
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Only four research groups did not follow the recom-
mended 1:1 dilution. Interestingly, their factors span a
range from 1:6 up to 4:1 (line (c) in Table 3). This gener-
ally mirrors the seductive nature of the staining proced-
ure [13] and the requests the researchers have towards
an easy and quick application. The concern of Stocks
[82] that the relative concentrations of PI, SYTO9 and
the nucleic acids are of crucial importance is mostly
neglected by the users.
At first glance the same holds true for the incubation
procedure (line (d) in Table 3), however, this might be a
more severe problem. Twenty-two of the users did not
state the procedure or relied on the manufacturer’s in-
structions. Some others reduced the recommended 15-
minute incubation to 10 minutes [6,7,20], while others
extended the incubation time between the BacLight
stains and their samples to 20 or even 30 minutes
[83,92-94]. However, the finding of Tawakoli et al. [7]
that the stained cells under investigation changed or
even lost their viability shortly after intercalation of the
dyes suggests that the “simple” incubation time is a cru-
cial and potentially destructive factor. It is to question
whether a time of 10, 20 or 30 minutes (“in the dark”,
but at room temperature, and only once at 2°C [93])
may exert a deteriorating effect on the outcome of the
staining procedure. This is of specific importance when
the influence of antibacterial substances is assessed like
the widely used and often studied chlorhexidine (CHX)
or essential oils (EO), which affect the integrity of the
bacterial cell membrane.
All three phenomena - FRET and double staining
[41,82,83], potential impact of exopolymers [21], and the
observation of decreasing vitality during the staining
procedure [7] - point towards an overestimation of PI,
i.e., of dead cells. For an example Tomás and colleagues
assessed the effects of CHX in saliva as measured with
the aid of the BLA [89-91]. Especially 30 seconds after
rinsing with CHX they revealed a very strong bactericidal
action. However, their magnitude was in line with former
(independent) conventional plating assays of the same re-
search group [99]. Noteworthy, this research group had ac-
ceptable outcomes with the use of the staining procedures
and presented convincing data regarding the antibacterial
effect of different CHX concentrations, rinsing regimes
[89,90] and influencing factors [91]. In sum, however, it
cannot be cleared whether there is an artificial shifting to-
wards “dead” values as long as no concomitant compari-
son with appropriate conventional parameters is made.
Different trials concerning comparisons were con-
ducted by the BLA users (line (e) in Table 3), with the
exception of [5] altogether with inappropriate methods.
In our opinion (see next paragraph) only the plating effi-
ciency (PE) as a relative parameter is appropriate, butnot the CFU. Decker [5] registered the total bacterial
counts (BC) as well as the CFU, both parameters being
the mathematical basis to calculate the PE [8]. Neverthe-
less, she did not determine the corresponding PE values.
Therefore, the positive and negative conclusions regard-
ing the reliability of her different staining procedures
cannot be justified.
Assessments of CFU were conducted by different au-
thors, either in independent earlier publications [99-101]
before the authors switched to the usage of the BLA
[19,90,91], or simultaneously with their BLA measure-
ments [7,19,23,86,89,92,96-98]. Quite astonishingly all
these very different author groups tried to compare the
relative parameter “percentage of vital bacteria”, as mon-
itored by the BLA, with the absolute parameter CFU as
assessed by plate counting. No wonder that the counts
did not fit with the BLA in 7 of the 9 cases (line (h) in
Table 3).
Finally, we tried to judge whether the authors were satis-
fied with the outcome of the BLA (line (i) in Table 3). This
was more or less true in the majority of cases, independent
of validation and comparison, and independent of the
agreement of the BLA with the other (inappropriate)
methods. Some authors were nearly delighted [92,93].
Taking all objective observations into consideration, in-
correct statements were published by the users of the
BLA. Some of the users [6,7,21,23,41,71,82,83,86] even de-
scribe and discuss the shortcomings of their commercial
stains. Similarly, as already mentioned, Davey [10] in her
recent review criticizes some limitations or “stumbling
blocks” in flow cytometry. No single stain or staining
method has been found to be suitable for all organisms
[102]. Consequently, the modus operandi of different
fluorescent stains has even been described in several re-
views (see for example [102-104]). The second limiting
factor deserving consideration is the need for further
method development and protocol adjustment, even when
similar protocols have already been published. For ex-
ample, microorganisms may need pretreatment, which
may also be different for gram-positives and gram-
negatives, such as the use of EDTA. Thus, such protocol
modifications are necessary for each new bacterial species
tested (“strain- and matrix-specific optimization of the
protocol”) [10,97,105,106]. Again, it should be noted that
the dental biofilm comprises, in a conventional view, of as
many as or even more than 1000 diverse species [8,84]
embedded in a complex matrix [8]. A current genetic ana-
lysis even discloses 10 000 species-level phylotypes [107].
Colony Forming Units (CFU) and Plating Efficiency (PE) for
comparison with vital stains
The only parameter that can be used for comparing the
reliability of vital stains (of any kind) is the plating effi-
ciency (PE). This is irrespective of the difficulties of
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PE can be calculated by relating plate counts (CFU) and
total microscopic counts (MC), as conducted by Netuschil
and coworkers with supragingival plaque biofilm bacteria
ex vivo [108-110]. Table 4 (data taken from [8]) signifies
a good relationship between Fluorescein Diacetate/Eth-
idium Bromide (FDA/EB) based vital fluorescence data
(VF) and corresponding PE values. When PE and VF
were assessed from the same plaque sample the PE re-
sulted in lower values than VF (in 7 of 9 comparisons
including about 500 samples, Table 4). This is to be ex-
pected because more microorganisms should be vital
than viable.
Moreover, Table 4 illustrates that initial dental plaque
consists mainly of bacteria that are either not culturable
or are dead. This has been proven by cultivation [111]
or by cultivation and concomitant vital fluorescence
(VF) [108-110]. In two hour old plaque samples Weiger
et al. [109] calculated a mean PE of 30% compared to a
mean value of 22% vital bacteria in VF (FDA/EB). In
their study with 120 minute old adhering biofilm bac-
teria Tawakoli et al. [7] found vitalities ranging from 42%
to 66% (cf. their Table 4).
PE data were not assessed in the investigation by
Tawakoli et al. [7]. They discussed “a certain variance
between the different combinations” of stains, which “re-
sulted in three groups: equal distribution [2 stains], more
dead bacteria vs. viable [1 stain], more viable vs. dead
bacteria [2 stains]” (see the results in their article,
Table 3). However, without an accompanying calculation
of PE an important question remains to be answered:
Which of these (groups of ) vital stains reflect (or do not
reflect) the microbial reality? Similar to other authors
[19,23,86,89,92,96-98], Tawakoli et al. [7] assessed theTable 4 Vital fluorescence (VF%) results compared to the corr
(PE%) (data taken from [8])
Reference n1 Plaque age (Days)
WEIGER et al. 1992 [108] 200 1
2
3
WEIGER et al. 1994 [115] 132 1
2
3
VON OHLE 1995 CF. [109] 211 1
2
3
NETUSCHIL et al. 1995 [110] 160 1
2
3
1Number of independent plaque samples.
2Rough relation between VF(%) and PE(%).
3n.a.: not available – in this first study different plaque samples (however, from oneCFU, which only reflect the pure number of bacteria in
their samples. No wonder that the latter authors state
the following in their results: “A correlation between the
number of bacteria detected with CFU and the number
of viable bacteria, detected with staining techniques,
could not be observed.”
Dependence of the results of vitality testing on the stain’s
concentration
Stocks [82] clearly stated that not only the relative con-
centrations of PI and SYTO9, but also their relationship
to DNA are of crucial importance. This equals Acridine
Orange (AO), which is falsely named a vital stain, and
which stains nucleic acids either green (this was wrongly
believed to be vital) or red (this was wrongly believed to
be dead). It could easily be shown that dilutions or con-
centrations of only factor 2 lead to remarkable shifts in
the green/red images [8]. This clarifies that the so-called
“vitality values,” as assessed with AO, are dependent on
its concentration, on pH and other factors, as well as on
the relationship of the dye (whether in an adequate
concentration or not) to the actual amount of stainable
nucleic acids, DNA and/or RNA. Citations from the
MOLECULAR PROBES Product Information [81], in-
cluding (I) that an “appropriate mixture” of the dyes is
necessary for reliable testing, and (II) that the number
of bacteria to be tested has to be known and standard-
ized in a species-specific manner, clarifies that the afore-
mentioned statement concerning AO, in accordance
with Stocks [82], also applies to the SYTO 9/PI stain.
However, no relevant concentration-dependency was
found for the FDA/EB staining. Staining solutions con-
taining the same basic concentration of FDA/EB were
applied in different studies, where, due to differing studyesponding bacteriological parameter plating efficiency
VF (%) ± SD Relation2 PE (%) ± SD
69.8 ± 16.0 n.a.3 60.4 ± 30.3
78.0 ± 14.7 n.a. 91.9 ± 30.1
81.3 ± 10.9 n.a. 82.4 ± 26.8
42.9 ± 20.7 < 47.8 ± 21.8
76.3 ± 17.5 > 58.8 ± 18.0
86.3 ± 7.8 > 73.5 ± 30.6
57 ± 18 < 75 ± 35
73 ± 20 > 53 ± 20
79 ± 18 > 55 ± 20
52.1 ± 17.2 > 43.9 ± 27.2
83.3 ± 12.9 > 77.3 ± 26.1
90.8 ± 6.1 > 83.7 ± 17.0
patient each) were taken for assessment of either VF(%) or PE(%).
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ranged from 5 μl [112,113] to 50 μl [114], and even up
to 500 μl [110,115], without changing the outcomes of
the VF assessments [8].
The majority of the commercial staining components
act via passive physicochemical distribution patterns,
which are assumed to be different in (real) viable and
(real) dead microbial cells. This also holds true for EB;
however the color of EB cannot change due to concen-
tration, pH or other physicochemical parameters [8]. In
contrast, the non-fluorescent FDA penetrates the cell
membranes of living cells, and is cleaved only in a meta-
bolically active cell by different enzymes, mainly ester-
ases [8,116,117], to yield the fluorescing Fluorescein.
Thus, a functioning metabolism is a necessary prerequis-
ite for positive intracellular (vital) staining. Similar to the
red EB counter stain, the green Fluorescein staining is
neither hampered nor changed by physicochemical
effects.
Vital fluorescence assessments in dental biofilm research
It is to question why the “traditional” VF stains of FDA
and EB used in oral biofilm research should be replaced
with other substances that exert a similar health risk
(see next paragraph) and are not proven to be suitable
and reliable in biofilm studies. Regarding FDA/EB, an as-
sortment of existing publications (apart from numerous
cell culture and cytotoxicity investigations) can be cited
from research groups Netuschil [108-110,112,114,115,
118-124], Brecx [125-128], Arweiler/Auschill [113,129-143]
and others [144-155]. In this context the FDA/EB vital
fluorescence staining was routinely used together with
Confocal Laser Scanning Microscopy (CLSM) [119,124,131,
134-136,139,140,143,153] to establish the three-dimensional
vitality pattern of the (early) dental biofilm or to docu-
ment the antibacterial effects of dental materials, mou-
thrinse solutions as well as food preservatives.
Worth noting is that the FDA/EB VF staining method
discriminates very well between the bactericidal effects
of diverse mouth rinse preparations [8,110,113,120,123,Table 5 Comparison of some staining principles in regard to
Staining principle Stain(s)
(combinations)
Co
microb
Single spe
in vitr
Vital fluorescence (FDA/EB) cf. [8,110,112] Fluorescein diacetate,
Ethidium bromide
+
BacLight® (cf. Table 3) Syto 9,
Propidium iodide
-
Staining according to [10,102] Diverse substances ?
1Proven.
2Generally to assume, partly proven.
?Partly known or not known or not available from the diverse substances.125,126,129,133,137,138,145]. Also, due to easy handling
and to the independency of calibration procedures as well
as concentration and other physical and chemical parame-
ters, the results obtained via FDA/EB staining can be
compared between different studies and even between dif-
ferent research groups.
Mutagenicity of staining solutions
Tawakoli et al. [7] argue that EB, which stains by inter-
calation in DNA, is mutagenic. Without any question,
this fact has to be taken into consideration [8]. Because
high amounts of EB are used in genetic research around
the world, research laboratories are aware of this com-
pound and its carcinogenicity. The authors of this article
often experienced deep negativity towards EB, and only
upon mentioning the name of this compound amongst
the laboratory staff caused great concern. Nevertheless,
at four different universities in Germany (Tübingen,
Homburg/Saarland, Dresden and Freiburg, 1980 till
2009) we received general permission from the safety au-
thorities to dispose our FDA/EB staining solutions in the
normal waste due to the very scarce amounts of EB
used.
The handling procedures of EB correspond with
sources found in the internet [Wikipedia, Ethidium
bromide, June 2012, see {further citations} there]: “Eth-
idium bromide is not regulated as hazardous waste at
low concentrations {17}.” Due to its use in veterinary
medicine as an anti-trypanosoma medicament {1}, its
non-mutagenic effect in mice during a “subchronic car-
cinogenicity study” {11} and its effect even as an anti-
tumorigenic chemotherapeutic agent {12} the “above
studies do not support the commonly held idea that eth-
idium bromide is a potent mutagen in humans….”
Nevertheless, Wikipedia recommends to be cautious and
the “material should be handled according to the mater-
ial safety data sheet….”
Ironically, the alternatives PI and the SYTO 9 are also
potentially hazardous chemicals. Here also we would
like to cite [81] the MOLECULAR PROBES Producttheir suitability for biofilm research
mparison with
iological data (PE)
Concentration
independency
Suitability for
biofilm research
Potentially
mutagenic
cies
o
Biofilm ex vivo
or in situ
++ Proven
[8,110,112-115]
Proven
(cf. Table 4)
+1
- Questionable
(cf. Table 3)
Questionable
(cf. Table 3)
+2
? Non-existing or
questionable
Non-existing or
questionable
?
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pidium iodide and SYTO 9 stain bind to nucleic acids.
Propidium iodide is a potential mutagen, and we have
no data addressing the mutagenicity or toxicity of the
SYTO 9 stain. Both reagents should be used with appro-
priate care …. As with all nucleic acid stains, solutions
containing these reagents should be poured through acti-
vated charcoal before disposal. The charcoal must then
be incinerated to destroy the dyes.”
Thus, it seems that the difference between EB and
other intercalating dyes (for an example see [156]) is not
their potential mutagenicity, but the fact that the muta-
genicity of EB has been commonly known for decades.
In contrast, laboratory staff and other users of these che-
micals are not aware of the similar risk that PI, SYTO 9
and other nucleic stains could have.
Summary
Table 5 presents some “puzzle pieces” that are part of
this debate. As pointed out (cf. Davey [10] as well as
Pamp et al. [11]) a plethora of possibilities exist concern-
ing vital stains, staining methods, and staining principles.
For example, Tawakoli et al. [7] used combinations of
several stains, which were in part related to the FDA/EB
combination (FDA, cFDA, TCFDA and EB) or resembled
more the BacLight drawer (SYTO 9/PI, Sytox red).
An inherent aspect concerning the suitability of staining
methods is the dependency on the stains’ concentrations
of the results. Table 4 lists the literature showing the inde-
pendency of concentration of the FDA/EB vital staining.
In contrast, the evidence does not seem to exist for a vast
majority of the other stains.
It is compelling that “vital stains” (or however they
might be named) and, even more important, their nu-
merous combinations are directly comparable to appro-
priate conventional bacteriological data. This cannot be
the assessment of CFU, but of PE. As depicted in Table 4
corresponding data exists for FDA/EB. To the best of
our knowledge this does not hold true for the often used
BLA (cf. Table 3 and corresponding text).
In summary, our concluding statements are as follows:
– The nomenclature regarding “viability” and “vitality”
should be used with appropriate care. Per
definitionem no kind of stain used for bacteria can
prove their “viability”. Thus, such stains generally
should be named “vital stains”.
– According to the BLA manual itself and the
corresponding literature, the kit is not suitable for
natural multispecies biofilms research. The kit is
meant for use on a single defined bacterial species in
a concentration of staining solution that was
determined following a thorough calibration
procedure.– As a consequence of the kit's limitations, there is a
strong assumption that the results obtained with
several stains are influenced not only by physical
and chemical parameters, but also by the
relationship between total bacterial counts (viable,
vital or dead) and the amount of the stain used in
the test. Thus, the vitality data collected are prone
to a completely unknown percentage of artificial
shifting.
– Contrarily, no corresponding concentration-
dependency (or “relationship-dependency”) was
found with respect to FDA/EB. Moreover, the green
intracellular (vital) Fluorescein staining originates
only in metabolically active (bacterial) cells.
– Colony forming units (CFU) are not a useful
parameter to compare to the results of “vitality
staining”. Instead the plating efficiency (PE) should
be used, if possible to conduct.
– It is a common belief that EB is highly mutagenic.
However, the documented data is controversial. EB
seems not to be a hazardous mutagen in humans. In
this respect, researchers and laboratory staff should
be aware that alternative staining compounds may
also be or even are mutagenic.
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